London Daily

Focus on the big picture.
Sunday, Sep 28, 2025

Everything you need to know about Pfizer’s COVID-19 vaccine

Everything you need to know about Pfizer’s COVID-19 vaccine

Reported breakthrough in race to find coronavirus vaccine welcomed by scientists and leaders, but experts caution many questions remain.

Raising hopes for a major victory in the fight against the coronavirus pandemic, drugmakers Pfizer and BioNTech have said their experimental vaccine may be 90 percent effective at preventing COVID-19.

The announcement on Monday reverberated across the world, with stock markets surging to new records and political leaders welcoming the late-stage trial results – even as scientists and doctors cautioned many questions remained unanswered and warned any celebration would be premature.

As the efforts to contain a disease that has killed more than 1.25 million people and ravaged livelihoods globally, here is all you need to know about the promising vaccine.

What was announced?


The drugmakers’ trial involves some 44,000 people in six countries, half of whom have been administered with the vaccine, while the other half were given a placebo – a treatment designed to have no effect.

Monday’s data is from an interim analysis that was conducted after 94 participants in the continuing trial developed COVID-19. Fewer than nine of them who caught the disease had been given the vaccine.

To confirm the efficacy rate, Pfizer said it would continue its trial until there were 164 COVID-19 cases among volunteers, a number that the Food and Drug Administration (FDA) has agreed is enough to tell how well the vaccine is working.

The data, however, have yet to be peer-reviewed or published in a medical journal. Pfizer said it would do so once it has the results from the entire trial.

Outside experts said key details of the data need to be analysed and cautioned that many questions remain, including whether the vaccine can prevent severe disease or complications, how long it will protect against infection and how well it will work in the elderly.

How does this vaccine work?


When you get vaccinated, you are usually given either a weakened or a dead part of the virus, or the bacteria that causes an illness. In this way, the vaccine does not make you ill, but your body recognises that it is a foreign element and it mounts an immune response. This means that when your body comes across the real bug that causes that illness, it will be ready to attack it straight away.

The way this new vaccine works is called mRNA, meaning that you are not actually being injected with parts of the virus or a weakened form of it, but you are actually being administered with a part of the genetic code of the coronavirus. This tricks the body into producing some of the viral proteins itself so that the immune system then detects these proteins and starts to produce a defensive response to them.

What was the reaction?


Investors piled into banks stocks, airlines and other economically sensitive companies that had been battered by months of coronavirus-led lockdowns and travel bans, pushing major US stock indexes to fresh record highs.

Pfizer shares were indicated 6 percent higher in New York, while BioNTech’s US stock leapt 18 percent.

The World Health Organization said the results were very positive, but warned there was a funding gap of $4.5bn that could slow access to tests, medicines and vaccines in low- and middle-income countries.

Experts also warned there could be major challenges in distributing the vaccine, especially in poorer countries where power supplies are inadequate, as it must be stored at industrial deep-freeze temperatures to be effective.

What’s next?


Pfizer and BioNTech said they plan to apply to the FDA for emergency approval to use the vaccine by the end of the month, when they will have two months of safety data on about half of trial participants. This has raised the possibility of a regulatory decision as soon as December.

To save time, the companies began manufacturing the vaccine before they knew whether it would be effective. They now expect to produce up to 50 million doses, or enough to protect 25 million people, this year.

Pfizer said it expects to produce up to 1.3 billion doses of the vaccine in 2021.

Who is lining up to buy it?


Pfizer and BioNTech have a $1.95bn contract with the US government to deliver 100 million vaccine doses beginning this year. They have also reached supply agreements with the European Union, the United Kingdom, Canada and Japan.

Comments

Oh ya 5 year ago
So the title says everything you need to know. Well why not tell the folks what is in the vaccine? Like in most there are a bunch of poison things you do not want to put in your body like mercury, aluminum, formaldehyde, parts of aborted babies. But the sheeple will line up for the jab and the drug companies will make billions. Your life your body do as you wish, there is no law about being stupid

Newsletter

Related Articles

0:00
0:00
Close
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
Nvidia Pledges Up to $100 Billion Investment in OpenAI to Power Massive AI Data Center Build-Out
U.S. Signals ‘Large and Forceful’ Support for Argentina Amid Market Turmoil
Nvidia and Abu Dhabi’s TII Launch First AI-&-Robotics Lab in the Middle East
Vietnam Faces Up to $25 Billion Export Loss as U.S. Tariffs Bite
Europe Signals Stronger Support for Taiwan at Major Taipei Defence Show
Indonesia Court Upholds Military Law Amid Concerns Over Expanded Civilian Role
Larry Ellison, Michael Dell and Rupert Murdoch Join Trump-Backed Bid to Take Over TikTok
Trump and Musk Reunite Publicly for First Time Since Fallout at Kirk Memorial
Vietnam Closes 86 Million Untouched Bank Accounts Over Biometric ID Rules
Explosive Email Shows Sarah Ferguson Begged Forgiveness from Jeffrey Epstein After Taking His Money
Corrupt UK Politician Ed Davey Demands Elon Musk’s Arrest for Supporting Democracy
UK, Canada, and Australia Officially Recognise Palestine in Historic Shift
Alibaba Debuts Open-Source Deep Research Agent with Benchmarks Rivaling OpenAI
Marcos Faces Legacy-Defining Crisis as Flood Projects Scandal Sparks Massive Tide of Protests
China’s Micro-Drama Boom Turns Stalled Real Estate Projects into Lavish Film Sets
New Eye Drops Show Promise in Replacing Reading Glasses for Presbyopia
'Company Got 5,189 H-1B Visas, Then Laid Off 16,000 Americans': US Defends New $100,000 H-1B Visa Fee
Golf legend tells Omar she should be 'sent back to Somalia' after her Kirk comments
EU Set to Bar Big Tech from New Financial Data Access Scheme
China Bans Livestreaming and AI in Religion Amid Crackdown on Shaolin Temple Scandal
×